Thus, COX inhibitors, as known as nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce inflammation by inhibiting COX-2 expression, thereby reducing tumor growth and lowering cancer risk and mortality [14,15,16,17]. Here, PTGS2 is linked to neoplasm.